BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,726,331 | -19.2% | 125,234 | -2.5% | 0.04% | -15.9% |
Q2 2023 | $5,849,084 | +8.1% | 128,382 | -3.7% | 0.04% | +10.0% |
Q1 2023 | $5,408,353 | -20.5% | 133,342 | -0.1% | 0.04% | -25.9% |
Q4 2022 | $6,801,896 | -6.9% | 133,449 | -1.6% | 0.05% | -14.3% |
Q3 2022 | $7,304,493 | -17.3% | 135,620 | -1.4% | 0.06% | -12.5% |
Q2 2022 | $8,836,571 | -15.6% | 137,577 | +1.9% | 0.07% | +4.3% |
Q1 2022 | $10,468,598 | +11.5% | 135,009 | +23.5% | 0.07% | -12.7% |
Q4 2021 | $9,387,462 | +4.9% | 109,360 | -1.7% | 0.08% | -4.8% |
Q3 2021 | $8,950,894 | -3.3% | 111,288 | -3.2% | 0.08% | -5.7% |
Q2 2021 | $9,253,556 | -7.6% | 114,951 | -3.2% | 0.09% | -7.4% |
Q1 2021 | $10,013,520 | +2.0% | 118,728 | -3.0% | 0.10% | -5.0% |
Q4 2020 | $9,821,055 | -3.6% | 122,396 | -3.4% | 0.10% | -10.7% |
Q3 2020 | $10,187,847 | -10.3% | 126,683 | -4.0% | 0.11% | -13.2% |
Q2 2020 | $11,361,928 | +6.3% | 131,962 | +0.3% | 0.13% | -14.6% |
Q1 2020 | $10,684,766 | -5.8% | 131,602 | -3.0% | 0.15% | +28.0% |
Q4 2019 | $11,341,213 | -6.7% | 135,628 | -2.4% | 0.12% | -15.1% |
Q3 2019 | $12,153,169 | +13.5% | 138,941 | +6.2% | 0.14% | +16.8% |
Q2 2019 | $10,710,718 | -2.8% | 130,778 | -3.5% | 0.12% | -4.0% |
Q1 2019 | $11,019,782 | +18.3% | 135,528 | -4.2% | 0.12% | +6.0% |
Q4 2018 | $9,315,965 | -16.4% | 141,537 | -2.1% | 0.12% | -0.8% |
Q3 2018 | $11,142,974 | +4.1% | 144,545 | -0.3% | 0.12% | -6.3% |
Q2 2018 | $10,709,000 | -44.9% | 145,024 | -51.5% | 0.13% | -45.0% |
Q1 2018 | $19,453,000 | +93.3% | 299,090 | +92.8% | 0.23% | +100.9% |
Q4 2017 | $10,064,000 | – | 155,100 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
Third Point | 4,000,000 | $344,400,000 | 4.72% |
Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |